INIS
antibiotics
18%
bacillus
27%
biopsy
28%
bones
5%
breasts
36%
cancer
36%
carcinomas
6%
collisions
6%
comparative evaluations
5%
defects
5%
dendrites
54%
diseases
18%
drugs
36%
environmental exposure
9%
epidermis
6%
evaluation
9%
gulf coast
54%
increasing
9%
keratin
6%
leukemia
54%
lupus
54%
males
12%
malignancies
12%
management
63%
melanin
6%
melanomas
12%
metabolites
18%
metastases
36%
morphology
12%
mycobacterium
54%
neoplasms
59%
nose
5%
patients
100%
pigments
6%
populations
30%
range
23%
sheets
6%
side effects
54%
skin
78%
spectra
54%
stains
36%
sun
6%
surgery
39%
texas
54%
therapy
27%
trauma
9%
tumor cells
54%
tumors
59%
women
18%
wounds
54%
Medicine and Dentistry
Acid Fast Bacterium
32%
Antibiotic Resistance
10%
Antibiotics
10%
Biopsy
5%
Cancer
10%
Case Report
54%
Cell Population
5%
Cells
16%
Chronic Myelomonocytic Leukemia
54%
Clinical Feature
10%
Culture
32%
Dendritic Cell Sarcoma
54%
Diagnosis
43%
Disease
10%
Environmental Exposure
10%
Epidermis
5%
Epithelial Cell
5%
Epithelioid Cell
5%
Evaluation Study
10%
Examination
5%
Face
5%
Hand Foot Syndrome
54%
Histogenesis
5%
Incidence
10%
Infection
21%
Keratin
5%
Lesion
5%
Male
10%
Melanin
5%
Metastatic Breast Cancer
9%
Middle Age
5%
Morphology
10%
Mycobacterium abscessus
10%
Mycobacterium Avium-Intracellulare Infection
54%
Neoplasm
54%
Nodular Melanoma
10%
Patient
64%
Patient Referral
10%
Pigment
5%
Postoperative Management
15%
Prodrug
9%
Prognosis
5%
Scalp
5%
Skin
10%
Skin Biopsy
21%
Smear
21%
Specimen
21%
Squamous Cell Carcinoma
5%
Surgery
21%
Therapeutic Procedure
21%
Keyphrases
Biological Dressings
40%
Biosynthetic Wound Dressings
54%
Collision Tumor
10%
Collision Type
10%
Cutaneous Abnormalities
10%
Dermatological Adverse Effects
10%
Indeterminate Dendritic Cell Tumor
54%
Keratosis
10%
Large Wound
13%
Medical Comorbidity
13%
Micrographic Surgery
13%
Multidrug Treatment
10%
Nasal Defect
13%
Offending Drugs
10%
Palmar-plantar Erythrodysesthesia
54%
Papulonodules
10%
Porcine Xenograft
54%
Postoperative Management
27%
Second-intention Healing
13%
Squamomelanocytic Tumor
54%
Therapy-systemic
10%
Tumor Margin
13%
Wound Depth
13%
Wound Management
27%
Wound Reconstruction
13%
Xeloda
10%